Intellectual property and COVID-19 medicines: Why a WTO waiver may not be enough

Is there a link between youth suicide and COVID-19? Suicidologist explains
24 February 2021
US to distribute 25 million cloth masks against COVID-19
24 February 2021

Intellectual property and COVID-19 medicines: Why a WTO waiver may not be enough

The COVID-19 pandemic, and the race to make vaccines and other useful technologies more accessible to people around the world, has once again highlighted the tension between intellectual property rights and the promotion of public health.

Comments are closed.